Every record from PeptideMeter · page 14
Runs dual-wavelength detection as standard and reports named related substances rather than totals only. Measured offset against the reference laboratory is -0.024 pp on 569 paired lots. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-020865 | CJC-1295 (no DAC) | CPC | CPC-2509-L1903 | 2025-Q4 | 97.75 | 6.32 | 106.3 | Supplier-supplied | 2 | FAIL |
| AX-2025-018459 | Tirzepatide | WWB | WWB-2506-T2732 | 2025-Q4 | 99.75 | 3.93 | 100.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018546 | Semax | WWB | WWB-2506-S4098 | 2025-Q4 | 99.93 | 7.92 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020094 | ARA-290 | GGPeps | GGPE-2511-F8277 | 2025-Q4 | 98.80 | 2.43 | 106.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020478 | BPC-157 | KP | KP-2511-M5346 | 2025-Q4 | 98.05 | 5.33 | 95.1 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018485 | CJC-1295 with DAC | WWB | WWB-2509-J2816 | 2025-Q4 | 99.14 | 4.14 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019121 | IGF-1 LR3 | JEEP | JEEP-2510-K4647 | 2025-Q4 | 98.63 | 4.64 | — | Supplier-supplied | 0 | PASS |
| AX-2025-018626 | Retatrutide | QYB | QYB-2507-R5467 | 2025-Q4 | 98.16 | 3.95 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-021144 | Ipamorelin | WXT | WXT-2510-B5160 | 2025-Q4 | 99.10 | 3.71 | 105.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019625 | Semaglutide | Homopeptide | HOMO-2505-N2173 | 2025-Q4 | 99.29 | 6.48 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020864 | CJC-1295 (no DAC) | CPC | CPC-2509-L1903 | 2025-Q4 | 97.80 | 6.57 | 97.5 | Supplier-supplied | 2 | FAIL |
| AX-2025-019713 | L-Glutathione (reduced) | HJ | HJ-2507-P3062 | 2025-Q4 | 98.74 | 7.23 | 94.4 | Supplier-supplied | 0 | PASS |
| AX-2025-019874 | L-Glutathione (reduced) | SWB | SWB-2506-B5296 | 2025-Q4 | 98.80 | 9.91 | 107.1 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020000 | CJC-1295 with DAC | ERP | ERP-2507-A6393 | 2025-Q4 | 99.03 | 3.80 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2025-018819 | SS-31 (Elamipretide) | QSC | QSC-2502-M8050 | 2025-Q3 | 99.93 | 4.69 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020307 | Semaglutide | MKM | MKM-2507-D3230 | 2025-Q4 | 98.93 | 5.02 | 107.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018711 | GHRP-6 | QSC | QSC-2508-F6725 | 2025-Q4 | 99.93 | 4.81 | 91.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020425 | Tirzepatide | KP | KP-2504-V4847 | 2025-Q3 | 98.17 | 4.52 | 89.7 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-019107 | BPC-157 | JEEP | JEEP-2507-V4206 | 2025-Q3 | 99.41 | 4.97 | 97.7 | Laboratory-retained | 0 | PASS |
| AX-2025-020028 | CJC-1295 (no DAC) | ERP | ERP-2506-B7535 | 2025-Q4 | 98.48 | 5.89 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019601 | TB-500 | Homopeptide | HOMO-2504-G1782 | 2025-Q3 | 99.11 | 4.34 | 103.5 | Laboratory-retained | 2 | MARGINAL |
| AX-2025-019000 | PT-141 (Bremelanotide) | FGP | FGP-2509-H2645 | 2025-Q4 | 99.89 | 3.21 | 107.4 | Supplier-supplied | 0 | PASS |
| AX-2025-018699 | Retatrutide | QSC | QSC-2502-D6580 | 2025-Q3 | 98.65 | 7.10 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-021156 | TB-500 | WXT | WXT-2502-A5571 | 2025-Q3 | 98.46 | 2.79 | 94.2 | Supplier-supplied | 2 | FAIL |
| AX-2025-021304 | CJC-1295 with DAC | BCH | BCH-2505-T7755 | 2025-Q3 | 98.16 | 8.20 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019422 | Semaglutide | Homopeptide | HOMO-2505-V8950 | 2025-Q3 | 99.17 | 5.82 | 106.1 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020692 | Semaglutide | GL Biochem | GLBI-2505-V8283 | 2025-Q3 | 97.33 | 4.81 | 105.1 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-021142 | TB-500 | WXT | WXT-2506-K5484 | 2025-Q3 | 98.00 | 5.16 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-019730 | PEG-MGF | HJ | HJ-2507-S2872 | 2025-Q3 | 98.23 | 6.96 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019428 | Semaglutide | Homopeptide | HOMO-2506-V8763 | 2025-Q3 | 98.62 | 5.10 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018558 | IGF-1 LR3 | WWB | WWB-2504-J3824 | 2025-Q3 | 98.30 | 7.53 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020830 | GHRP-6 | SGN | SGN-2504-X1136 | 2025-Q3 | 98.45 | 4.24 | 98.1 | Laboratory-retained | 1 | FAIL |
| AX-2025-020901 | Semaglutide | CPC | CPC-2504-G2724 | 2025-Q3 | 98.51 | 4.61 | 90.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019134 | PEG-MGF | TFC | TFC-2507-M4201 | 2025-Q3 | 97.54 | 3.86 | 105.1 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018860 | Desmopressin | QSC | QSC-2505-N8999 | 2025-Q3 | 99.82 | 5.00 | 103.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018662 | CJC-1295 (no DAC) | QYB | QYB-2505-C5547 | 2025-Q3 | 99.79 | 4.98 | 106.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021308 | CJC-1295 with DAC | BCH | BCH-2505-T7755 | 2025-Q3 | 98.58 | 7.64 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019203 | TB-500 | TFC | TFC-2503-R5803 | 2025-Q3 | 99.27 | 3.75 | 96.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018992 | N-Acetyl Semax Amide | FGP | FGP-2508-R1956 | 2025-Q3 | 99.25 | 8.46 | 103.8 | Supplier-supplied | 0 | PASS |
| AX-2025-020644 | MOTS-c | SSA | SSA-2503-S7755 | 2025-Q3 | 99.49 | 5.23 | 92.6 | Supplier-supplied | 0 | PASS |